MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

MARIMED INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$0.06−0.00 (-3.39%)

Close on Oct 19, 2026

Market cap: $22.78M
P/E (TTM): –
Dividend yield: –

MARIMED INC. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31
Cash & Equivalents	8.88	7.28	15	9.74	30	3.00	0.74	4.10	1.29	0.57	0.16	0.99	0.01	0.01	0.12
Short-Term Investments	–	0	0.09	0.12	0.25	1.36	1.45	–	–	–	–	–	–	–	–
Cash & Short-Term Investments	8.88	7.28	15	9.86	30	4.36	2.19	4.10	1.29	0.57	0.16	0.99	0.01	0.01	0.12
Receivables	9.11	8.74	7.20	4.16	1.67	6.68	1.67	5.38	1.45	0.53	0.19	0.05	0.05	–	–
Inventory	37	33	25	19	9.77	6.83	1.22	0.09	–	–	–	–	–	–	–
Prepaid Expenses & Other	–	–	–	–	–	–	–	–	–	–	0.04	0.02	–	0.09	–
Other Current Assets	3.83	3.39	3.51	7.28	1.44	0.58	0.19	0.13	0.36	0.02	0.04	0.00	0.00	–	–
Total Current Assets	59	54	51	44	45	21	7.38	16	4.97	2.44	0.95	1.30	1.10	0.12	0.19
Property, Plant & Equipment	89	94	89	72	62	46	43	34	26	5.31	0.08	0.00	–	–	–
Gross Property, Plant & Equipment	117	116	104	82	69	51	46	36	27	–	–	–	–	–	–
Accumulated Depreciation	-27	-22	-15	-10	-6.95	-4.89	-3.14	-2.16	-1.50	-1.14	-0.87	–	–	–	–
Construction in Progress	–	–	–	–	–	–	–	12	17	–	–	–	–	–	–
Long-Term Investments	–	0	0.22	0	0	1.17	1.32	1.67	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	7.72	8.73	9.72	4.93	5.08	5.25	5.79	–	–	–	–	–	–	–	–
Goodwill	24	16	12	8.08	2.07	2.07	–	–	–	–	–	–	–	–	–
Intangible Assets	17	19	17	14	0.16	2.23	2.36	0.19	0.33	–	–	–	–	–	–
Other Long-Term Assets	0.93	11	13	1.02	0.10	0.08	0.18	0.08	0.25	0.20	–	–	–	–	–
Total Assets	203	207	196	152	123	76	62	83	32	8.56	3.72	1.65	1.65	0.12	0.19
Accounts Payable	15	13	9.00	6.63	5.10	5.04	4.72	3.92	2.83	0.47	0.60	0.39	1.08	0.09	–
Accrued Expenses	9.51	4.44	3.55	3.09	3.15	2.73	5.40	1.59	1.41	1.69	–	0.01	–	–	–
Short-Term Debt	–	–	–	–	–	–	23	–	–	–	–	–	–	–	–
Current Debt	–	–	–	–	–	–	23	–	–	–	–	–	–	–	–
Current Portion of Leases	1.95	1.99	1.95	1.27	1.07	1.01	0.92	–	–	–	–	–	–	–	–
Current Income Taxes Payable	27	22	14	11	16	0.90	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	1.39	1.33	–	–	–	–	4.20	–	–	0.23	–	–	–	–	–
Other Current Liabilities	–	–	–	–	0.00	0.02	0.86	–	–	0.23	–	0.23	0.23	–	–
Total Current Liabilities	59	50	31	26	27	23	37	9.95	15	6.12	5.65	1.53	1.53	0.64	0.35
Long-Term Debt	–	–	–	26	17	11	–	–	–	–	–	–	–	–	–
Long-Term Leases	6.62	7.55	8.46	4.17	4.57	4.82	5.40	–	–	–	–	–	–	–	–
Operating Lease Liabilities	8.57	9.54	10	5.45	5.65	5.83	6.34	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	0	0.10	0.10	0.10	0.10	0.10	0.10	0.34	0.24	0.24	–	–	–	–	–
Total Liabilities	138	129	107	57	49	54	55	21	21	9.11	5.65	3.58	3.58	0.64	0.35
Total Debt	–	–	–	26	17	11	23	–	–	–	–	–	–	–	–
Preferred Stock	0	0	0	0	0	–	–	–	–	–	–	–	–	–	–
Common Stock	0.40	0.38	0.38	0.34	0.33	0.31	0.23	0.21	0.18	0.06	–	0.03	–	–	–
Additional Paid-In Capital	179	173	171	142	135	113	112	87	22	8.46	7.01	6.06	6.06	-0.49	-0.95
Retained Earnings	-128	-113	-100	-84	-97	-105	-107	-26	-12	-11	-10	-8.97	-8.97	-1.21	-0.38
Treasury Stock	–	–	–	–	–	–	–	–	-0.03	–	–	–	–	–	–
Shareholders' Equity	–	–	–	–	–	–	–	62	11	-0.55	-1.93	-1.93	-1.01	-0.51	-0.16
Noncontrolling Interest	-1.86	-1.75	-1.65	-1.51	-1.56	-0.58	-0.55	-0.22	0.18	0.56	0.05	-0.24	-0.24	–	–
Total Equity	50	59	69	57	36	8.10	6.33	62	11	-0.55	-1.93	-1.93	-1.01	-0.51	-0.16
Total Liabilities & Equity	203	207	196	152	123	76	62	83	32	8.56	3.72	1.65	-1.93	0.12	0.19
Shares Outstanding(shares)	397	381	375	341	334	314	228	211	177	64	32	32	32	25	0

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 35.6%
Operating margin: -1.5%
Net margin: -9.1%
Return on equity, FY2025: –

Financial strength

Current ratio: 0.92
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 13.2%

Valuation

P/E ratio: –
Price to sales: 0.14
Price to book: –
Dividend yield: –